| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.3 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |